-
PF-543 Citrate
- names:
PF-543 Citrate
- CAS号:
1415562-83-2
MDL Number: - MF(分子式): C33H39NO11S MW(分子量): 657.73
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM004618-10mg | 10mg | 98.22% | ¥ 7425.00 | ¥ 7425.00 | 2-3天 | ¥ 0.00 | ||
| YZM004618-5mg | 5mg | 98.22% | ¥ 1027.00 | ¥ 1027.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | PF-543 Citrate |
| CAS号 | 1415562-83-2 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C33H39NO11S |
| 分子量 Molecular Weight | 657.73 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(152.04 mM)H2O : 50 mg/mL(76.02 mM;Need ultrasonic)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | PF43 Citrate (Sphingosine Kinase 1 Inhibitor II Citrate) is a novel cellermeant inhibitor ofSPHK1with aKiof 4.3 nM and more than 100old selectivity for SPHK1 over SPHK2. |
| Application1 | |
| Application2 | |
| Application3 |
PF-543 Citrate (Sphingosine Kinase 1 Inhibitor II Citrate) 为新颖的可渗透细胞的SPHK1抑制剂,Ki值为 4.3 nM。PF-543 Citrate 对 SPHK1 的选择性为 SPHK2 的 100 倍以上。PF-543 Citrate (Sphingosine Kinase 1 Inhibitor II Citrate) is a novel cell-permeant inhibitor ofSPHK1with aKiof 4.3 nM and more than 100-fold selectivity for SPHK1 over SPHK2.
【1】.Schnute ME, et al. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem J. 2012 May 15;444(1):79-88.
【2】.Wang J, et al. Crystal Structure of Sphingosine Kinase 1 with PF-543. ACS Med Chem Lett. 2014 Oct 27;5(12):1329-33.
【3】.MacRitchie N, et al. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension. Cell Signal. 2016 Aug;28(8):946-55.
【2】.Wang J, et al. Crystal Structure of Sphingosine Kinase 1 with PF-543. ACS Med Chem Lett. 2014 Oct 27;5(12):1329-33.
【3】.MacRitchie N, et al. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension. Cell Signal. 2016 Aug;28(8):946-55.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


